Francesca Barone

Francesca Barone

Chief Tech/Sci/R&D Officer at CANDEL THERAPEUTICS, INC.

Net worth: 1 M $ as of 2026-08-30

49 year
Consumer Services
Health Technology

Profile

Francesca Barone is currently Chief Scientific Officer at Candel Therapeutics, Inc. since 2022.
Former positions include Director-Laboratories at the Institute of Translational Medicine, Associate Professor at the University of Birmingham from 2010 to 2019, and Head-Experimental Medicine at Senda Biosciences, Inc. from 2019 to 2021.
Education includes doctorates from Sapienza University of Rome and King's College London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-28 77,362 ( 0.1% ) 1 M $ 2026-08-30

Francesca Barone active positions

CompaniesPositionStart
CANDEL THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2020-10-31

Former positions of Francesca Barone

CompaniesPositionEnd
Corporate Officer/Principal 2021-10-31
Corporate Officer/Principal 2019-11-30
Institute of Translational Medicine
Corporate Officer/Principal -
See the detail of Francesca Barone's experience

Training of Francesca Barone

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Institute of Translational Medicine

  1. Stock Market
  2. Insiders
  3. Francesca Barone